>>9148298 lb
You folks in Delaware out to make up some signs saying
THANK YOU GOV. CARNEY
IF ITS GOOD ENOUGH FOR THE CHINESE
ITS GOOD ENOUGH FOR US!
And make sure to give the stiff-armed salute as you march along wearing your facemasks while staying 6 feet apart.
The Risks - Know Them - Avoid Them
https://www.erinbromage.com/post/the-risks-know-them-avoid-them
As I read this I though, Why are restaurants so cramped anyway?
I personally try to avoid restaurants because they are so crammed with people which makes it too noisy to talk comfortably.
It's almost as if someone was engineering the restaurants to support creating epidemics.
And what is the story with office buildings recirculating dirty air so that one sick person can infect 3 floors of a building? Why is the ventilating system designed like this? It doesn't have to be.
APOTEX DONATES HYDROXYCHLOROQUINE FOR A CLINICAL STUDY TO PREVENT INFECTION FROM COVID-19 WITH FRONT LINE HEALTH CARE WORKERS
https://www1.apotex.com/global/about-us/press-center/2020/03/23/apotex-donates-hydroxychloroquine-for-a-clinical-study-to-prevent-infection-from-covid-19-with-front-line-health-care-workers
Toronto, Ontario, March 20th – 2020 – Apotex, Canada’s largest pharmaceutical company, announced today that it is donating Hydroxychloroquine to accelerate a study examining if it prevents infection of COVID-19 in front-line healthcare employees.
The study, conducted by the University Health Network and Unity Health (St Michael's Hospital) in Toronto, aims to gather data from randomized controlled trials which is essential for informing the best practices in protecting our health care workers at this critical time. It is a PreExposure Prophylaxis randomized placebo controlled trial for front line health care workers including emergency room staff and ICU staff.
“We are committed to take whatever actions we can to support our healthcare community as they investigate possible treatments for COVID-19,” said Jeff Watson, President and CEO, Apotex. “Due to anticipated increased demand for this product, we have doubled our planned production outputs, and are in dialogue with governments about additional measures they may wish to take on this specific product.”
Process for the preparation of highly pure hydroxychloroquine or a salt thereof
https://patents.google.com/patent/CA2561987A1/en
Inventor Daqing Che Bhaskar Reddy Guntoori Sammy Chris Duncan Laura Kaye Montemayor
Current Assignee Apotex Pharmachem Inc
The present invention relates to a process for the manufacture of the antimalarial drug hydroxychloroquine, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]-ethylamino]ethanol sulfate. In particular, this novel process delivers highly pure hydroxychloroquine or a salt thereof which contains very low but acceptable levels of a particularly difficult to remove impurity (des-ethyl hydroxychloroquine).